Cheyne Capital Management Uk Llp Has Trimmed By $2.84 Million Its Synergy Pharmaceuticals Del (SGYP) Position; P. H. Glatfelter Company (GLT) Had 2 Bullish Analysts

May 27, 2018 - By Winifred Garcia

P. H. Glatfelter Company (NYSE:GLT) Logo

Cheyne Capital Management Uk Llp decreased Synergy Pharmaceuticals Del (SGYP) stake by 87.29% reported in 2017Q4 SEC filing. Cheyne Capital Management Uk Llp sold 1.42M shares as Synergy Pharmaceuticals Del (SGYP)’s stock declined 21.49%. The Cheyne Capital Management Uk Llp holds 206,500 shares with $462,000 value, down from 1.63M last quarter. Synergy Pharmaceuticals Del now has $402.19M valuation. The stock decreased 2.98% or $0.05 during the last trading session, reaching $1.63. About 1.75M shares traded. Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) has declined 62.55% since May 27, 2017 and is downtrending. It has underperformed by 74.10% the S&P500.




Among 3 analysts covering PH Glatfelter Co (NYSE:GLT), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. PH Glatfelter Co had 13 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets on Friday, August 18 with “Buy”. As per Friday, October 27, the company rating was maintained by BMO Capital Markets. The rating was upgraded by BMO Capital Markets to “Outperform” on Friday, May 5. On Wednesday, November 2 the stock rating was upgraded by BMO Capital Markets to “Outperform”. The company was downgraded on Wednesday, December 7 by DA Davidson. The rating was maintained by BMO Capital Markets with “Buy” on Friday, June 9. As per Friday, July 14, the company rating was maintained by BMO Capital Markets. The rating was downgraded by BMO Capital Markets to “Market Perform” on Wednesday, December 7. The rating was maintained by BMO Capital Markets on Friday, September 22 with “Buy”. Sidoti initiated the stock with “Buy” rating in Wednesday, December 16 report. See P. H. Glatfelter Company (NYSE:GLT) latest ratings:

Analysts await Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) to report earnings on August, 8. They expect $-0.16 earnings per share, up 51.52% or $0.17 from last year’s $-0.33 per share. After $-0.15 actual earnings per share reported by Synergy Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 6.67% negative EPS growth.

Cheyne Capital Management Uk Llp increased Illumina Inc (Prn) stake by 5.17 million shares to 5.50 million valued at $5.99M in 2017Q4. It also upped Citrix Sys Inc (Prn) stake by 1.28M shares and now owns 1.30M shares. Priceline Grp Inc (Prn) was raised too.

Among 8 analysts covering Synergy Pharmaceuticals (NASDAQ:SGYP), 6 have Buy rating, 1 Sell and 1 Hold. Therefore 75% are positive. Synergy Pharmaceuticals had 46 analyst reports since August 25, 2015 according to SRatingsIntel. Cantor Fitzgerald initiated the stock with “Buy” rating in Thursday, June 1 report. As per Monday, June 26, the company rating was maintained by BTIG Research. The rating was maintained by Canaccord Genuity with “Buy” on Friday, November 10. The rating was maintained by H.C. Wainwright on Monday, January 8 with “Buy”. The firm has “Buy” rating given on Friday, January 20 by Rodman & Renshaw. Citigroup maintained the shares of SGYP in report on Wednesday, March 16 with “Neutral” rating. The firm has “Buy” rating given on Wednesday, October 18 by H.C. Wainwright. The firm earned “Buy” rating on Thursday, August 10 by Oppenheimer. Canaccord Genuity maintained it with “Buy” rating and $1300 target in Friday, May 11 report. The rating was maintained by H.C. Wainwright on Monday, December 4 with “Buy”.

Investors sentiment decreased to 1.22 in Q4 2017. Its down 0.68, from 1.9 in 2017Q3. It dropped, as 21 investors sold SGYP shares while 34 reduced holdings. 24 funds opened positions while 43 raised stakes. 125.65 million shares or 14.56% less from 147.06 million shares in 2017Q3 were reported. Moreover, Teacher Retirement Sys Of Texas has 0% invested in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Fny Managed Accounts Ltd Llc reported 0% of its portfolio in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Creative Planning accumulated 32,105 shares or 0% of the stock. Susquehanna Gp Llp stated it has 0.01% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Nantahala Management Ltd Liability Corporation reported 0.69% stake. Hightower Ltd Liability Company owns 802,982 shares for 0.01% of their portfolio. Hsbc Hldgs Public Ltd Co holds 0% of its portfolio in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) for 23,742 shares. Proshare Advsr Ltd Limited Liability Company holds 169,802 shares or 0% of its portfolio. Janney Montgomery Scott Limited Liability Company reported 0% of its portfolio in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Da Davidson Com invested in 141,053 shares. Raymond James Fincl Svcs Advisors has 0% invested in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Bruce & owns 100,000 shares. Stratos Wealth Prtnrs Ltd invested in 0% or 4,000 shares. Signaturefd Ltd Liability Co has 10,000 shares for 0% of their portfolio. Cambridge Invest Rech invested 0% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP).

More important recent Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) news were published by: Seekingalpha.com which released: “Synergy Pharmaceuticals Investors: Refocus Away From Management” on May 17, 2018, also Seekingalpha.com published article titled: “Synergy Pharmaceuticals: Q1 Earnings Preview”, Seekingalpha.com published: “Synergy Pharmaceuticals: Activist Group Reaches 26.1 Million Shares” on May 06, 2018. More interesting news about Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) was released by: Seekingalpha.com and their article: “Synergy Pharmaceuticals: The Short Covering Has Begun” with publication date: May 13, 2018.

Investors sentiment increased to 1.48 in 2017 Q4. Its up 0.15, from 1.33 in 2017Q3. It is positive, as 15 investors sold P. H. Glatfelter Company shares while 33 reduced holdings. 20 funds opened positions while 51 raised stakes. 39.79 million shares or 0.15% less from 39.85 million shares in 2017Q3 were reported. Arizona State Retirement Systems owns 73,254 shares for 0.02% of their portfolio. State Common Retirement Fund invested in 46,900 shares. Pub Employees Retirement Of Ohio stated it has 7,889 shares or 0% of all its holdings. Barrow Hanley Mewhinney Strauss Ltd Company has 135,524 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 2,445 shares in its portfolio. Pillar Pacific Cap Mngmt Lc accumulated 0.04% or 13,900 shares. Texas Permanent School Fund owns 29,461 shares or 0.01% of their US portfolio. Amer Int Grp Inc reported 0% in P. H. Glatfelter Company (NYSE:GLT). First Manhattan Company invested in 0.07% or 615,233 shares. Manufacturers Life Insur Co The holds 0% or 33,554 shares in its portfolio. Pnc Serv invested in 0.01% or 428,786 shares. First Interstate Retail Bank owns 6,345 shares. State Bank Of Ny Mellon holds 0% or 681,850 shares in its portfolio. Vanguard Grp Inc Inc stated it has 0% of its portfolio in P. H. Glatfelter Company (NYSE:GLT). State Of Alaska Department Of Revenue holds 8,697 shares.

The stock decreased 1.54% or $0.27 during the last trading session, reaching $17.26. About 224,050 shares traded or 27.15% up from the average. P. H. Glatfelter Company (NYSE:GLT) has declined 4.40% since May 27, 2017 and is downtrending. It has underperformed by 15.95% the S&P500.

P. H. Glatfelter Company (NYSE:GLT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.